Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Building a business through economic uncertainty: tales from the biotech trenches Building a business through economic uncertainty: tales from the biotech trenches
Blog May 8, 2023
Building a business through economic uncertainty: tales from the biotech trenches
U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare
Blog April 24, 2023
U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare
Reducing real world data lag time for improved patient outcomes Reducing real world data lag time for improved patient outcomes
Blog March 8, 2023
Reducing real world data lag time for improved patient outcomes
Understanding a rare disease through the lens of real world and prevalence data Understanding a rare disease through the lens of real world and prevalence data
Blog February 28, 2023
Understanding a rare disease through the lens of real world and prevalence data
Blog January 10, 2023
The Drugs to Watch in 2023
UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition
Blog December 19, 2022
UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition
Five IDNs to watch in 2023 Five IDNs to watch in 2023
Blog December 6, 2022
Five IDNs to watch in 2023
Modeling the monkeypox breakout: Mutation rates and the potential for outbreaks Modeling the monkeypox breakout: Mutation rates and the potential for outbreaks
Blog November 16, 2022
Modeling the monkeypox breakout: Mutation rates and the potential for outbreaks
Bringing the patient voice into clinical trials with clinical outcome assessments Bringing the patient voice into clinical trials with clinical outcome assessments
Blog November 10, 2022
Bringing the patient voice into clinical trials with clinical outcome assessments
Seven RNA technology companies to keep an eye on Seven RNA technology companies to keep an eye on
Blog November 8, 2022
Seven RNA technology companies to keep an eye on